Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 231-236 , April 2010

Unsaturated fatty acids as cytoprotective agents in the pancreatic β-cell

  • Noel G. Morgan

      Affiliations

    • Corresponding Author InformationCorrespondence to: Endocrine Pharmacology Group, Institute of Biomedical & Clinical Science, Peninsula Medical School, John Bull Building, Plymouth PL6 8BU, UK.
    • ,
  • Shalinee Dhayal

References 

  1. Del Prato S. Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies. Diabet. Med. 2009;26:1185–1192
  2. Talchai C, Lin HV, Kitamura T, Accili D. Genetic and biochemical pathways of beta-cell failure in type 2 diabetes. Diabet. Obes. Metab. 2009;11(Suppl 4):38–45
  3. Robertson RP. Beta-cell deterioration during diabetes: what's in the gun?. Trends Endocrinol. Metab. 2009;20:388–393
  4. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr. Rev. 2008;29:351–366
  5. Kahn SE, Zraika S, Utzschneider KM, Hull RL. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia. 2009;52:1003–1012
  6. V. Poitout, J. Amyot, M. Semache, B. Zarrouki, D. Hagman, G. Fontes, Glucolipotoxicity of the pancreatic beta cell, Biochim. Biophys. Acta, 2009 doi: 10.1016/j.bbalip.2009.08.006.
  7. Nolan CJ, Madiraju MS, ghingaro-Augusto V, Peyot ML, Prentki M. Fatty acid signaling in the beta-cell and insulin secretion. Diabetes. 2006;55(Suppl 2):S16–S23
  8. Morgan NG, Dhayal S. G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell. Biochem. Pharmacol. 2009;78:1419–1427
  9. Newsholme P, Keane D, Welters HJ, Morgan NG. Life and death decisions of the pancreatic beta-cell: the role of fatty acids. Clin. Sci. (Lond). 2007;112:27–42
  10. Haber EP, Procopio J, Carvalho CR, Carpinelli AR, Newsholme P, Curi R. New insights into fatty acid modulation of pancreatic beta-cell function. Int. Rev. Cytol. 2006;248:1–41
  11. zevedo-Martins AK, Monteiro AP, Lima CL, Lenzen S, Curi R. Fatty acid-induced toxicity and neutral lipid accumulation in insulin-producing RINm5F cells. Toxicol. In Vitro. 2006;20:1106–1113
  12. Eitel K, Staiger H, Brendel MD, et al. Different role of saturated unsaturated fatty acids in beta-cell apoptosis. Biochem. Biophys. Res. Commun. 2002;299:853–856
  13. Welters HJ, Tadayyon M, Scarpello JH, Smith SA, Morgan NG. Mono-unsaturated fatty acids protect against beta-cell apoptosis induced by saturated fatty acids, serum withdrawal or cytokine exposure. FEBS Lett. 2004;560:103–108
  14. Nolan CJ, Larter CZ. Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it?. J. Gastroenterol. Hepatol. 2009;24:703–706
  15. Wei D, Li J, Shen M, et al. Cellular Production of {omega}-3 PUFAs and Reduction of {omega}-6/{omega}-3 ratios in the Pancreatic {beta}-cells and Islets Enhance Insulin Secretion and Confer Protection against Cytokine-induced Cell Death. Diabetes. 2009;
  16. Furstova V, Kopska T, James RF, Kovar J. Comparison of the effect of individual saturated and unsaturated fatty acids on cell growth and death induction in the human pancreatic beta-cell line NES2Y. Life Sci. 2008;82:684–691
  17. Dhayal S, Welters HJ, Morgan NG. Structural requirements for the cytoprotective actions of mono-unsaturated fatty acids in the pancreatic beta-cell line, BRIN-BD11. Br. J. Pharmacol. 2008;153:1718–1727
  18. Diakogiannaki E, Dhayal S, Childs CE, Calder PC, Welters HJ, Morgan NG. Mechanisms involved in the cytotoxic and cytoprotective actions of saturated versus monounsaturated long-chain fatty acids in pancreatic {beta}-cells. J. Endocrinol. 2007;194:283–291
  19. Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes. 2003;52:726–733
  20. Suresh Y, Das UN. Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus. Prostaglandins Leukot. Essent. Fatty Acids. 2001;64:37–52
  21. Moffitt JH, Fielding BA, Evershed R, Berstan R, Currie JM, Clark A. Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. Diabetologia. 2005;48:1819–1829
  22. Hennige AM, Ranta F, Heinzelmann I, et al. Over-expression of kinase negative protein kinase C{delta} in pancreatic {beta}-cells protects mice from diet-induced glucose intolerance and {beta}-cell dysfunction. Diabetes. 2009;
  23. Lupi R, Dotta F, Marselli L, et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes. 2002;51:1437–1442
  24. Koshkin V, Dai FF, Robson-Doucette CA, Chan CB, Wheeler MB. Limited mitochondrial permeabilization is an early manifestation of palmitate-induced lipotoxicity in pancreatic beta-cells. J. Biol. Chem. 2008;283:7936–7948
  25. Abaraviciene SM, Lundquist I, Salehi A. Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities. Cell Mol. Life Sci. 2008;65:2256–2265
  26. Simon MN, zevedo-Martins AK, Amanso AM, Carvalho CR, Curi R. Persistent activation of Akt or ERK prevents the toxicity induced by saturated and polyunsaturated fatty acids in RINm5F beta-cells. Toxicol. In Vitro. 2008;22:1018–1024
  27. Hellemans K, Kerckhofs K, Hannaert JC, Martens G, Van VP, Pipeleers D. Peroxisome proliferator-activated receptor alpha-retinoid X receptor agonists induce beta-cell protection against palmitate toxicity. FEBS J. 2007;274:6094–6105
  28. Moore PC, Ugas MA, Hagman DK, Parazzoli SD, Poitout V. Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion. Diabetes. 2004;53:2610–2616
  29. Kelpe CL, Moore PC, Parazzoli SD, Wicksteed B, Rhodes CJ, Poitout V. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. J. Biol. Chem. 2003;278:30015–30021
  30. Hellemans KH, Hannaert JC, Denys B, et al. Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase. PLoS ONE. 2009;4:e7266
  31. Kwon G, Marshall CA, Pappan KL, Remedi MS, McDaniel ML. Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets. Diabetes. 2004;53(Suppl 3):S225–S232
  32. Eitel K, Staiger H, Brendel MD, Brandhorst H, Bretzel RG, Haring HU, et al. [Apoptosis induced by free fatty acids]. Med. Klin. (Munich). 2003;98:248–252
  33. El-Assaad W, Buteau J, Peyot ML, et al. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology. 2003;144:4154–4163
  34. Li J, Liu X, Ran X, et al. Sterol regulatory element-binding protein-1c knockdown protected INS-1E cells from lipotoxicity, Diabetes Obes.. Metab. 2009;
  35. Cnop M. Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes. Biochem. Soc. Trans. 2008;36:348–352
  36. Papadimitriou A, King AJ, Jones PM, Persaud SJ. Anti-apoptotic effects of arachidonic acid and prostaglandin E2 in pancreatic beta-cells. Cell Physiol. Biochem. 2007;20:607–616
  37. Beeharry N, Lowe JE, Hernandez AR, et al. Linoleic acid and antioxidants protect against DNA damage and apoptosis induced by palmitic acid. Mutat. Res. 2003;530:27–33
  38. Alkhunaizi AM, Yaqoob MM, Edelstein CL, et al. Arachidonic acid protects against hypoxic injury in rat proximal tubules. Kidney Int. 1996;49:620–625
  39. Stoddart LA, Smith NJ, Milligan G. International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol. Rev. 2008;60:405–417
  40. Wellendorph P, Johansen LD, Brauner-Osborne H. Molecular pharmacology of promiscuous 7TM receptors sensing organic nutrients. Mol. Pharmacol. 2009;
  41. Schnell S, Schaefer M, Schofl C. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40. Mol. Cell Endocrinol. 2007;263:173–180
  42. Briscoe CP, Tadayyon M, Andrews JL, et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 2003;278:11303–11311
  43. Itoh Y, Kawamata Y, Harada M, et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature. 2003;422:173–176
  44. Brown AJ, Goldsworthy SM, Barnes AA, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 2003;278:11312–11319
  45. Nilsson NE, Kotarsky K, Owman C, Olde B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem. Biophys. Res. Commun. 2003;303:1047–1052
  46. Sum CS, Tikhonova IG, Neumann S, et al. Identification of residues important for agonist recognition and activation in GPR40. J. Biol. Chem. 2007;282:29248–29255
  47. Lauffer LM, Iakoubov R, Brubaker PL. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes. 2009;58:1058–1066
  48. Chu ZL, Jones RM, He H, et al. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology. 2007;148:2601–2609
  49. Overton HA, Babbs AJ, Doel SM, et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 2006;3:167–175
  50. Thompson MD, Siminovitch KA, Cole DE. G protein-coupled receptor pharmacogenetics. Methods Mol. Biol. 2008;448:139–185
  51. Nagasumi K, Esaki R, Iwachidow K, et al. Over expression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice. Diabetes. 2009;58:1067–1076
  52. Doshi LS, Brahma MK, Sayyed SG, et al. Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat. Metabolism. 2009;58:333–343
  53. Kebede MA, Alquier T, Latour MG, Poitout V. Lipid receptors and islet function: therapeutic implications?. Diabetes Obes. Metab. 2009;11(Suppl 4):10–20
  54. Hara T, Hirasawa A, Sun Q, Koshimizu TA, Itsubo C, Sadakane K, et al. Flow cytometry-based binding assay for GPR40 (FFAR1; free fatty acid receptor 1). Mol. Pharmacol. 2009;75:85–91
  55. Costanzi S, Neumann S, Gershengorn MC. Seven transmembrane-spanning receptors for free fatty acids as therapeutic targets for diabetes mellitus: pharmacological, phylogenetic, and drug discovery aspects. J. Biol. Chem. 2008;283:16269–16273
  56. Richieri GV, Anel A, Kleinfeld AM. Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry. 1993;32:7574–7580
  57. Richieri GV, Kleinfeld AM. Unbound free fatty acid levels in human serum. J. Lipid Res. 1995;36:229–240
  58. T. Wallin, Z. Ma, H. Ogata et al., Facilitation of fatty acid uptake by CD36 in insulin-producing cells reduces fatty-acid-induced insulin secretion and glucose regulation of fatty acid oxidation, Biochim. Biophys. Acta, 2009, doi:10.1016/j.bbalip.2009.11.002.
  59. Ehehalt R, Sparla R, Kulaksiz H, Herrmann T, Fullekrug J, Stremmel W. Uptake of long chain fatty acids is regulated by dynamic interaction of FAT/CD36 with cholesterol/sphingolipid enriched microdomains (lipid rafts). BMC. Cell Biol. 2008;9:45
  60. Eyre NS, Cleland LG, Tandon NN, Mayrhofer G. Importance of the carboxyl terminus of FAT/CD36 for plasma membrane localization and function in long-chain fatty acid uptake. J. Lipid Res. 2007;48:528–542
  61. Koonen DP, Glatz JF, Bonen A, Luiken JJ. Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim. Biophys. Acta. 2005;1736:163–180
  62. Coort SL, Willems J, Coumans WA, van der Vusse GJ, Bonen A, Glatz JF, et al. Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake. Mol. Cell Biochem. 2002;239:213–219
  63. Busch AK, Gurisik E, Cordery DV, et al. Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic beta-cells from lipoapoptosis. Diabetes. 2005;54:2917–2924
  64. Preston AM, Gurisik E, Bartley C, Laybutt DR, Biden TJ. Reduced endoplasmic reticulum (ER)-to-Golgi protein trafficking contributes to ER stress in lipotoxic mouse beta cells by promoting protein overload. Diabetologia. 2009;
  65. Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 2008;29:42–61
  66. Diakogiannaki E, Welters HJ, Morgan NG. Differential regulation of the endoplasmic reticulum stress response in pancreatic beta-cells exposed to long-chain saturated and monounsaturated fatty acids. J. Endocrinol. 2008;197:553–563
  67. Lai E, Bikopoulos G, Wheeler MB, Rozakis-Adcock M, Volchuk A. Differential activation of ER stress and apoptosis in response to chronically elevated free fatty acids in pancreatic beta-cells. Am. J. Physiol. Endocrinol. Metab. 2008;294:E540–E550
  68. Cunha DA, Hekerman P, Ladriere L, et al. Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J. Cell Sci. 2008;121:2308–2318
  69. Karaskov E, Scott C, Zhang L, Teodoro T, Ravazzola M, Volchuk A. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology. 2006;147:3398–3407

PII: S0952-3278(10)00062-1

doi: 10.1016/j.plefa.2010.02.018

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 231-236 , April 2010

Article Tools

* Image Usage & Resolution